Crosswalk Therapeutics, Inc.

United States of America

 
Total IP 10
Total IP Rank # 153,415
IP Activity Score 1.9/5.0    11
IP Activity Rank # 81,248

Patents

Trademarks
9 0
0 0
1 0
0
 
Last Patent 2025 - Engineered acid alpha-glucosidas...
First Patent 2015 - Human alpha-galactosidase variants

Latest Inventions, Goods, Services

2024 Invention Engineered acid alpha-glucosidase variants. The present disclosure provides engineered acid alpha...
Invention Engineered acid alpha-glucosidase variants. The present invention provides engineered acid alpha...
2022 Invention Human alpha-galactosidase variants. The present invention provides engineered human alpha-galact...
2020 Invention Engineered acid alpha-glucosidase variants. The present invention provides engineered acid alpha-...
Invention Human alpha-galactosidase variants. The present invention provides engineered human alpha-galacto...